A Phase 2b Randomised, Placebo Controlled Study of OligoG in Patients With Cystic Fibrosis
Status:
Active, not recruiting
Trial end date:
2021-07-10
Target enrollment:
Participant gender:
Summary
A double-blind, randomised study of OligoG DPI compared to placebo DPI, both on top of
standard-of-care, to assess safety, efficacy and tolerability. Adult patients with Cystic
Fibrosis will be included in the study.